EC fines Teva $502m over multiple sclerosis treatment Copaxone practices

By Yahoo! Finance | Nov 1, 2024 at 06:59 AM EST

The European Commission fined Teva Pharmaceuticals Industries €462.6m for anti-competitive practices related to multiple sclerosis treatment Copaxone. Teva extended patent protection, disseminated misleading information, and disparaged competitors to block market entry, violating EU regulations. Teva plans to appeal the decision.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.